From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance cellular reprogramming for aging research. The company operates across ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

NetTargets employs an AI system that combines multi-omics data with neural network modelling for drug discovery.

AI’s true power lies in pattern recognition across messy, real-world data: Natural language processing extracts phenotypes, comorbidities, and device usability feedback from unstructured clinical ...

Leiden researchers, led by Sebastian Pomplun, have developed a new method to screen hundreds of thousands of molecules for ...

Merck, a leading science and technology company, has entered into a partnership with Promega Corporation, a global life ...

Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles.

Spinal cord injury (SCI) remains a major unmet medical challenge, often resulting in permanent paralysis and disability with ...

For the first time, a drug shows effectiveness in adult human brain cells — an achievement long thought impossible.

Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer to help with drug discovery and shorten ...

On October 27, Thermo Fisher Scientific and Lundbeck both announced new collaborations with OpenAI. These moves represent a continuing trend of drug development companies inking deals with technology ...

Eli Lilly announced a partnership with chipmaker NVIDIA to build what it claims will be the “most powerful supercomputer ...